SSRI Antidepressant Birth Defect MDL — Cases Against GSK and Pfizer Resume After Pause

The multidistrict litigation (MDL) involving SSRI antidepressant birth defect claims against pharmaceutical giants GlaxoSmithKline (GSK) and Pfizer has...

The multidistrict litigation (MDL) involving SSRI antidepressant birth defect claims against pharmaceutical giants GlaxoSmithKline (GSK) and Pfizer has...